EcoDrugPlus

Proteasome (Prosome, Macropain) 26s Subunit, Non-Atpase, 14

Ensembl ID : ENSMSIG00000014615
Gene Symbol: PSMD14
1 Cross references
226 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Non-Atpase, 2

Ensembl ID : ENSMSIG00000009945
Gene Symbol: PSMD2
1 Cross references
221 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Non-Atpase, 3

Ensembl ID : ENSMSIG00000026576
Gene Symbol: PSMD3
1 Cross references
227 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Non-Atpase, 6

Ensembl ID : ENSMSIG00000014259
Gene Symbol: PSMD6
1 Cross references
227 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Non-Atpase, 7

Ensembl ID : ENSMSIG00000003185
Gene Symbol: PSMD7
1 Cross references
253 Possible Orthologues:

Proteasome (Prosome, Macropain) 26s Subunit, Non-Atpase, 8

Ensembl ID : ENSMSIG00000020246
Gene Symbol: PSMD8
1 Cross references
187 Possible Orthologues:

Proteasome (Prosome, Macropain) Subunit, Beta Type 1

Ensembl ID : ENSMSIG00000027998
Gene Symbol: PSMB1
1 Cross references
231 Possible Orthologues:

Proteasome (Prosome, Macropain) Subunit, Beta Type 10

Ensembl ID : ENSMSIG00000005972
Gene Symbol: PSMB10
1 Cross references
186 Possible Orthologues:

Proteasome (Prosome, Macropain) Subunit, Beta Type 2

Ensembl ID : ENSMSIG00000016704
Gene Symbol: PSMB2
1 Cross references
234 Possible Orthologues:

Proteasome (Prosome, Macropain) Subunit, Beta Type 3

Ensembl ID : ENSMSIG00000017213
Gene Symbol: PSMB3
1 Cross references
239 Possible Orthologues:

Proteasome (Prosome, Macropain) Subunit, Beta Type 5

Ensembl ID : ENSMSIG00000016401
Gene Symbol: PSMB5
1 Cross references
230 Possible Orthologues:

Proteasome (Prosome, Macropain) Subunit, Beta Type 6

Ensembl ID : ENSMSIG00000020722
Gene Symbol: PSMB6
1 Cross references
229 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).